Citation Impact
Citing Papers
Compliance of patients and physicians: experience and lessons from tuberculosis-II.
1983
No health without mental health
2007 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Under-Reporting of Adverse Drug Reactions
2006 Standout
Hypertrophic Scars and Keloids—A Review of Their Pathophysiology, Risk Factors, and Therapeutic Management
2009 Standout
UK malaria treatment guidelines 2016
2016
Guideline for Prevention of Surgical Site Infection, 1999
1999 Standout
Interferon-γ –Receptor Deficiency in an Infant with Fatal Bacille Calmette–Guérin Infection
1996
Neutrophils in the activation and regulation of innate and adaptive immunity
2011 Standout
Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence
2012 Standout
Guideline for Infection Control in Healthcare Personnel, 1998
1998
Tuberculosis control and elimination 2010–50: cure, care, and social development
2010 Standout
Keloids: a review of the literature
1990
Prevalence of childhood acne, ephelides, warts, atopic dermatitis, psoriasis, alopecia areata and keloid in Kaohsiung County, Taiwan: a community‐based clinical survey
2007
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
2007 Standout
Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccines
1991 Nature
New use of BCG for recombinant vaccines
1991 StandoutNature
Tuberculosis
2003
Guideline for infection control in health care personnel, 1998
1998
Nonadherence in Tuberculosis Treatment: Predictors and Consequences in New York City
1997
Tuberculosis vaccine development: goals, immunological design, and evaluation
2008
Clinical features of dominant and recessive interferon γ receptor 1 deficiencies
2004
Drivers of tuberculosis epidemics: The role of risk factors and social determinants
2009 Standout
UK malaria treatment guidelines
2007
On the Nature of Hypertrophic Scars and Keloids: A Review
1999 Standout
The Growing Burden of Tuberculosis
2003 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Interferon-γ: an overview of signals, mechanisms and functions
2003 Standout
Control of Tuberculosis
1967
Single Mucosal, but Not Parenteral, Immunization with Recombinant Adenoviral-Based Vaccine Provides Potent Protection from Pulmonary Tuberculosis
2004
Fatal Sepsis Following Intravesical Bacillus Calmette-Guerin Administration for Bladder Cancer
1990
Active community surveillance of the impact of different tuberculosis control measures, Tiruvallur, South India, 1968–2001
2006
HOW CELLS RESPOND TO INTERFERONS
1998 Standout
Guideline for Prevention of Surgical Site Infection, 1999
1999 Standout
Incidence and Treatment of Complications of Bacillus Calmette-Guerin Intravesical Therapy in Superficial Bladder Cancer
1992
Epidemiologic basis of tuberculosis control
1999
Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review
2008 Standout
In vitro studies on the choice of drugs for intermittent chemotherapy of tuberculosis
1966
A four-year follow-up of patients with quiescent pulmonary tuberculosis at the end of a year of chemotherapy with twice-weekly isoniazid plus streptomycin or daily isoniazid plus pas
1969
Complications of Bacillus Calmette-Guerin Immunotherapy in 1,278 Patients with Bladder Cancer
1986
MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY
2000 Standout
Tuberculosis: Commentary on a Reemergent Killer
1992 StandoutScience
The early bactericidal activity of drugs in patients with pulmonary tuberculosis.
1980 Standout
Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes
2005
The Immune Response in Tuberculosis
2013 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Guidelines for Preventing the Transmission of Tuberculosis in Health-Care Settings, with Special Focus on HIV-Related Issues
1990 Standout
Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein
1993 StandoutScience
OSTEITIS AND OTHER COMPLICATIONS CAUSED BY GENERALIZED BCG‐ITIS
1982
Long-Term Protection against Tuberculosis following Vaccination with a Severely Attenuated Double Lysine and Pantothenate Auxotroph ofMycobacterium tuberculosis
2005
The Immunology of Mycobacterial Infections
1982
Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee.
1999 Standout
Vaccine efficacy of an attenuated but persistent Mycobacterium tuberculosis cysH mutant
2007 StandoutNobel
Intravesical Bacillus Calmette-Guerin Reduces the Risk of Progression in Patients with Superficial Bladder Cancer: A Meta-analysis of the Published Results of Randomized Clinical Trials
2002 Standout
Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety.
1990
Presentation of mycobacterial antigens by human dendritic cells: lack of transfer from infected macrophages
1993 StandoutNobel
Works of A Lötte being referenced
ACONCURRENT COMPARISON OF INTERMITTENT (TWICE-WEEKLY) ISONIAZID PLUS STREPTOMYCIN AND DAILY ISONIAZID PLUS PAS IN THE DOMICILIARY TREATMENT OF PULMONARY TUBERCULOSIS; TUBERCULOSIS CHEMOTHERAPY CENTRE, MADRAS.
1964
Treatment of imported malaria in adults: a multicentre study in France
2005
Balance of risks and balance of costs regarding tuberculosis and antituberculous vaccination.
1979
[Complications induced by BCG vaccination: retrospective study].
1981
Second IUATLD study on complications induced by intradermal BCG-vaccination.
1988
BCG complication-Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics
1984
A bibliography of the complications of BCG vaccination. A comprehensive list of the world literature since the introduction of BCG up to July 1982, supplemented by over 100 personal communications.
1984
BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics.
1984
Evolution of the Rates of Tuberculous Infection in France and Calculation of the Annual Risk by Means of a Mathematical Model
1973